<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827602</url>
  </required_header>
  <id_info>
    <org_study_id>GEH-R-20068776</org_study_id>
    <nct_id>NCT04827602</nct_id>
  </id_info>
  <brief_title>Drug Allergy Labels After Drug Allergy Investigation</brief_title>
  <official_title>Drug Allergy Labels in Different Electronic Health Records After Drug Allergy Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Unit Of General Practice, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the degree of match between the drug allergy label in&#xD;
      the hospital's electronic health record and primary care's electronic health record among&#xD;
      patients who previously have been drug allergy tested.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who previously have been penicillin allergy tested in 2017 to 2019 at the Allergy&#xD;
      Clinic at Gentofte Hospital is included in the study. Patients are identified through a drug&#xD;
      allergy database at the department.&#xD;
&#xD;
      A letter describing the study and the data collection process will be sent to the patients'&#xD;
      General Practice offices (GP).&#xD;
&#xD;
      Data collection: The patients GP's are contacted by telephone where the information about the&#xD;
      drug allergy labels in their electronical medical charts are shared. On the same day as the&#xD;
      phone contact to the GP's office, the patient's electronical health record in the hospital&#xD;
      system is accessed in order to gain information about the current drug allergy registrations.&#xD;
&#xD;
      Predictors for the explanatory analysis is collected partly through the phone call to the GP&#xD;
      (such as numbers of patients and physicians at each GP and the electronic health system&#xD;
      used), from the hospital electronic health record (such as number of hospital admissions&#xD;
      since drug allergy testing) and from the drug allergy database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of matching drug allergy testing and drug allergy labels</measure>
    <time_frame>Baseline</time_frame>
    <description>Degree of match between allergy testing outcomes and registered drug allergy labels in primary care and hospital electronic health records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of match between registered drug allergy labels</measure>
    <time_frame>Baseline</time_frame>
    <description>Degree of match between registered drug allergy labels in primary care and hospital electronic health records</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Analysis of predictors for failure to update drug allergy labels</measure>
    <time_frame>Baseline</time_frame>
    <description>Exploratory analysis of predictors for failure to update the drug allergy labels. Predictors include sex, age, immediate/delayed index allergic reaction, drug allergy test results, patients pr GP, doctors pr GP, electronic system used, drug allergy test referrals from the same GP, drug allergy labels pr patient and admissions since drug allergy testing pr patient.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Drug Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Allergy tested group</arm_group_label>
    <description>Patients who have completed penicillin allergy testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Drug allergy label status in electronic health records</intervention_name>
    <description>Registered drug allergy labels in primary care and hospital electronic medical charts</description>
    <arm_group_label>Allergy tested group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is made up of patients who completed penicillin allergy testing in&#xD;
        2017 to 2019 at the Allergy Clinic, Copenhagen University Hospital - Herlev and Gentofte,&#xD;
        Copenhagen, Denmark. The study population is estimated to 900 participants from both the&#xD;
        Capital Region and Region Zealand.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Penicillin allergy tested at the Allergy Clinic, Copenhagen University Hospital -&#xD;
             Herlev and Gentofte, Copenhagen, Denmark in 2017-2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Lene H. Garvey</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allergy Clinic, Copenhagen University Hospital, Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allergy Clinic, Department of Dermato-Allergology, Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Lachover-Roth I, Sharon S, Rosman Y, Meir-Shafrir K, Confino-Cohen R. Long-Term Follow-Up After Penicillin Allergy Delabeling in Ambulatory Patients. J Allergy Clin Immunol Pract. 2019 Jan;7(1):231-235.e1. doi: 10.1016/j.jaip.2018.04.042. Epub 2018 May 22.</citation>
    <PMID>29800754</PMID>
  </results_reference>
  <results_reference>
    <citation>Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Kibicho J, Brousseau DC. Antibiotic Use After Removal of Penicillin Allergy Label. Pediatrics. 2018 May;141(5). pii: e20173466. doi: 10.1542/peds.2017-3466.</citation>
    <PMID>29678929</PMID>
  </results_reference>
  <results_reference>
    <citation>Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy. 2017 Sep;72(9):1288-1296. doi: 10.1111/all.13168. Epub 2017 Apr 26. Review.</citation>
    <PMID>28370003</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>Sara Fransson</investigator_full_name>
    <investigator_title>Ph.D student</investigator_title>
  </responsible_party>
  <keyword>drug allergy</keyword>
  <keyword>drug allergy labels</keyword>
  <keyword>penicillin allergy labels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Drug Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

